<p>U87MG cells were seeded in a 96-well plate at a density of 10,000 cells per well. Cells were pre-treated with Bortezomib (0.1μM) or DMSO in triplicate for 2 hours. Treated cells were infected with TC-83 at MOI: 0.1 (A) MOI: 1 (B) or MOI: 5 (C). The viral inoculum was removed and replaced with conditioned media. At 6, 12, 18 and 24 hours post infection supernatants were collected and analyzed by plaque assay. The graph is representative of 2 independent experiments performed in triplicate. Standard deviations were calculated accordingly. p<0.05(*). p≤0.0001 (**). U87MG cells were seeded in a 12-well plate at a density of 100,000 cells per well. Cells were pre-treated with Bortezomib (0.1μM) or DMSO for 2 hours. Treated cells were infected...
<p>(<b>a</b>) Stromal HS-5 cells were seeded in 96-well plates at the density of 10<sup>4</sup> cell...
Ph+ cells BV-173 (A+B) and TOM-1 (C+D) were seeded with DMSO and bortezomib at day 0. DMSO was emplo...
<p>Cultures were treated or not with a single dose of 0.5 nM BZ from time 0 to day 7 or from day 1 t...
<p>A) U87MG cells were seeded in a 96-well plate at a density of 10,000 cells per well. Cells were e...
<p>A) U87MG cells were seeded in a 96-well plate at a density of 10,000 cells per well. Cells were p...
<p>U87MG cells were pre-treated with Bortezomib at 0.1μM for 2 hours and then infected with VEEV TrD...
<p>A) U87MG cells were seeded in a 96-well plate at a density of 10,000 cells per well. Cells were p...
<p>(A). Frequency of apoptosis of RPMI 8226 and AMO1. Left panels: dot plots showing the frequency o...
<p>WT mice infected intraperitonealy with DENV2 were treated with bortezomib 6 hpi and analyzed at 2...
<p>A. Inhibition of active sites was measured in cells immediately after 1-h of treatment with borte...
<p>72 hour LPS-treated or untreated BzS, BzR, or I-BzR lines were ficolled and re-plated in the pres...
<p>(A) Model-estimated fold change and associated SE of [<sup>3</sup>H]CCK-8 accumulation (1 μM, 3 m...
<p>Infectious DENV in cell culture supernatant was measured using plaque assay, and the percent inhi...
<p>A) U87MGs were untreated, DMSO treated or pretreated with IKK inhibitors (1 µM) for 2 hours and 2...
<p>(A) Viability assay evaluated by trypan blue exclusion was performed in BC3 (left panel) and BCBL...
<p>(<b>a</b>) Stromal HS-5 cells were seeded in 96-well plates at the density of 10<sup>4</sup> cell...
Ph+ cells BV-173 (A+B) and TOM-1 (C+D) were seeded with DMSO and bortezomib at day 0. DMSO was emplo...
<p>Cultures were treated or not with a single dose of 0.5 nM BZ from time 0 to day 7 or from day 1 t...
<p>A) U87MG cells were seeded in a 96-well plate at a density of 10,000 cells per well. Cells were e...
<p>A) U87MG cells were seeded in a 96-well plate at a density of 10,000 cells per well. Cells were p...
<p>U87MG cells were pre-treated with Bortezomib at 0.1μM for 2 hours and then infected with VEEV TrD...
<p>A) U87MG cells were seeded in a 96-well plate at a density of 10,000 cells per well. Cells were p...
<p>(A). Frequency of apoptosis of RPMI 8226 and AMO1. Left panels: dot plots showing the frequency o...
<p>WT mice infected intraperitonealy with DENV2 were treated with bortezomib 6 hpi and analyzed at 2...
<p>A. Inhibition of active sites was measured in cells immediately after 1-h of treatment with borte...
<p>72 hour LPS-treated or untreated BzS, BzR, or I-BzR lines were ficolled and re-plated in the pres...
<p>(A) Model-estimated fold change and associated SE of [<sup>3</sup>H]CCK-8 accumulation (1 μM, 3 m...
<p>Infectious DENV in cell culture supernatant was measured using plaque assay, and the percent inhi...
<p>A) U87MGs were untreated, DMSO treated or pretreated with IKK inhibitors (1 µM) for 2 hours and 2...
<p>(A) Viability assay evaluated by trypan blue exclusion was performed in BC3 (left panel) and BCBL...
<p>(<b>a</b>) Stromal HS-5 cells were seeded in 96-well plates at the density of 10<sup>4</sup> cell...
Ph+ cells BV-173 (A+B) and TOM-1 (C+D) were seeded with DMSO and bortezomib at day 0. DMSO was emplo...
<p>Cultures were treated or not with a single dose of 0.5 nM BZ from time 0 to day 7 or from day 1 t...